Mission Bio Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2014
Lead Investor(s):N/A
Press
Claim your profile

Estimated Revenue & Financials

  • Mission Bio's estimated annual revenue is currently $11.5M per year.
  • Mission Bio's estimated revenue per employee is $155,000

Employee Data

  • Mission Bio has 74 Employees.
  • Mission Bio grew their employee count by 45% last year.
  • Mission Bio currently has 1 job openings.

Executive Contacts

NameTitle
Pat BrooksSr Vp Global Sales And Support
Brian TurcottPresident & Principal Consultant
Olav HerreraBusiness Development Manager
Manimozhi ManivannanDirector, Bioinformatics
Nianzhen LiDirector of Biochemistry
Dave RuffHead of Research
James FlynnSenior Product Manager
Harsha KavuriSr Director Strategy & Analytics
Huddee HoDirector Of Engineering
Keith JonesSenior Vice President, Development

Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. In 2014, the company was spun out of Adam Abate's lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio's precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team. Our mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Visit missionbio.com to learn more.

keywords:N/A

74

Number of Employees

$11.5M

Revenue (est)

1

Current Jobs

45%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.7M4310%N/A
Mission Bio
$11.5M7445%N/A
Rigel Pharmaceu...
$45M2904%N/A
ProTrials Resea...
$28.2M1823%N/A
Trace Genomics
$6.4M4137%N/A
Advanced Cell D...
$27.6M1788%N/A
CellMax Life
$6.2M4011%N/A
Vaxart
$4.2M33-15%N/A
Full Spectrum A...
$6.5M425%N/A
Calysta
$7.6M49-2%N/A

Mission Bio News

24-Aug-19 - First Commercial Platform with Mutations and CNV Insights ...

San Francisco-based Mission Bio Inc. launched an addition to its Tapestri Platform that provides it the ability to track the full scope genomics of ...

31-Aug-19 - Mission Bio’s Tapestri Platform Can Now Identify Both Mutations and Copy Number Variants from the Same Cells

Mission Bio, Inc., the pioneer in targeted single-cell DNA analysis and precision genomics, announced the launch of Copy Number Analysis, ...

12-Sep-19 - Gossamer Bio Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

“As we continue to advance our pipeline and mission to help better the lives of patients, we are tremendously grateful to Otello for his ...